Inspire Investing, LLC Adaptimmune Therapeutics PLC Transaction History

Inspire Investing, LLC

  • $959 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022
SELL
$1.33 - $2.28 $42,464 - $72,795
-31,928 Closed
0 $0
Q1 2022

Apr 21, 2022
BUY
$1.73 - $4.06 $20,280 - $47,595
11,723 Added 58.02%
31,928 $66,000
Q4 2021

Feb 14, 2022
BUY
$3.5 - $5.68 $16,842 - $27,332
4,812 Added 31.26%
20,205 $76,000
Q4 2021

Feb 03, 2022
BUY
$3.5 - $5.68 $53,875 - $87,432
15,393 New
15,393 $58,000

Others Institutions Holding ADAP

# of Institutions
83
Shares Held
150M
Call Options Held
60.8K
Put Options Held
5.8K
View Full List

About Adaptimmune Therapeutics PLC

ADAP Quotes by TradingView
  • Ticker ADAP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 163,370,000
  • Market Cap $98M
  • Description
  • Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...
More about ADAP
Track This Portfolio

Track Inspire Investing, LLC Portfolio

Follow Inspire Investing, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Inspire Investing, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email